Ascendis Pharma
ASND
ASND
35 hedge funds and large institutions have $585M invested in Ascendis Pharma in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
+4
Holders Change %
+12.9%
% of All Funds
0.87%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.17%
New
8
Increased
10
Reduced
12
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BBA
Baker Bros. Advisors
New York
|
+$9.19M |
2 |
O
OppenheimerFunds
New York
|
+$8.33M |
3 |
ACA
Avoro Capital Advisors
New York
|
+$4.36M |
4 |
VMI
VHCP Management II
New York
|
+$2.53M |
5 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
+$2.41M |
Top Sellers
1 |
DM
Deerfield Management
New York
|
-$3.38M |
2 |
Millennium Management
New York
|
-$2.48M |
3 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
-$2.24M |
4 |
NC
Nexthera Capital
New York
|
-$2.02M |
5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.99M |